Condition: Major Depressive Disorder (MDD) · Sponsor: Stony Brook University
This is mechanistic clinical trial that evaluates the role of one of the glutamate receptors (mGluR5) in cognitive behavioral therapy for insomnia (CBT-I) as a common pathway in improving sleep and depression.
This description comes directly from the study's public registry record.
Wendy Zhang · (631)-638-2053 · Wendy.Zhang@stonybrookmedicine.edu
Christine DeLorenzo, PhD · (631) 638-1523 · christine.delorenzo@stonybrookmedicine.edu
Always discuss trial participation with your own doctor first.
| Stony Brook University: Dept of Psychiatry | Stony Brook, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07076342